BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs2300478
,
FGF21
,
calcium channel activity
,
Leukemia
,
Leukocyte
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
peripheral site inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Assessing the role of colonic and other anatomical sites uptake by [18 F]FDG-PET/CT and immune-infla…
Dyhidro-β-agarofurans natural and synthetic as acetylcholinesterase and COX inhibitors: interaction …
Computational Investigation of Ligand Binding to the Peripheral Site in CYP3A4: Conformational Dynam…
Hydroxybenzoic Acids as Acetylcholinesterase Inhibitors: Calorimetric and Docking Simulation Studies…
A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treat…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma
SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Pa…
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Ca…
Prospective Study of the SoundBite™ Crossing System in Complex Peripheral CTOs
SoundBite™ Crossing System Pivotal Peripheral CTO Crossing Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ